162 related articles for article (PubMed ID: 11593156)
1. [Fatal toxic respiratory epitheliolysis. Subacute tracheo-bronchial desquamation in Stevens-Johnson syndrome].
Martin L; Hazouard E; Michalak-Provost S; Maurage C; Machet L
Rev Pneumol Clin; 2001 Sep; 57(4):297-301. PubMed ID: 11593156
[TBL] [Abstract][Full Text] [Related]
2. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation.
de Prost N; Mekontso-Dessap A; Valeyrie-Allanore L; Van Nhieu JT; Duong TA; Chosidow O; Wolkenstein P; Brun-Buisson C; Maître B
Crit Care Med; 2014 Jan; 42(1):118-28. PubMed ID: 23989174
[TBL] [Abstract][Full Text] [Related]
3. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
[TBL] [Abstract][Full Text] [Related]
4. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
[TBL] [Abstract][Full Text] [Related]
6. [Toxic epidermal necrolysis and Stevens-Johnson syndrome].
Roujeau JC
Rev Prat; 2007 Jun; 57(11):1165-70. PubMed ID: 17691257
[TBL] [Abstract][Full Text] [Related]
7. Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series.
Yip LW; Thong BY; Lim J; Tan AW; Wong HB; Handa S; Heng WJ
Allergy; 2007 May; 62(5):527-31. PubMed ID: 17313402
[TBL] [Abstract][Full Text] [Related]
8. [Is the lung a target organ in inflammatory bowel disease?].
Marvisi M; Fornasari G
Recenti Prog Med; 2001 Dec; 92(12):774-7. PubMed ID: 11822102
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced Lyell and Stevens-Johnson syndromes.
Prescrire Int; 2009 Feb; 18(99):20-2. PubMed ID: 19391288
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Gueudry J; Roujeau JC; Binaghi M; Soubrane G; Muraine M
Arch Dermatol; 2009 Feb; 145(2):157-62. PubMed ID: 19221260
[TBL] [Abstract][Full Text] [Related]
11. [Osteochondroplastic tracheobronchopathy].
Grünling S; Rosenhagen K; Ullrich W
Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Feb; 36(2):110-4. PubMed ID: 11269013
[TBL] [Abstract][Full Text] [Related]
12. Severe cutaneous adverse reactions to drugs.
Chia FL; Leong KP
Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):304-9. PubMed ID: 17620821
[TBL] [Abstract][Full Text] [Related]
13. A case of toxic epidermal necrolysis with lesions mostly on sun-exposed skin.
Mansur AT; Aydingöz IA
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):100-2. PubMed ID: 15752129
[TBL] [Abstract][Full Text] [Related]
14. Anaphylaxis and toxic epidermal necrolysis or Stevens-Johnson syndrome after nonmucosal topical drug application: fact or fiction?
Sachs B; Fischer-Barth W; Erdmann S; Merk HF; Seebeck J
Allergy; 2007 Aug; 62(8):877-83. PubMed ID: 17620064
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications.
Sotozono C; Ueta M; Koizumi N; Inatomi T; Shirakata Y; Ikezawa Z; Hashimoto K; Kinoshita S
Ophthalmology; 2009 Apr; 116(4):685-90. PubMed ID: 19243825
[TBL] [Abstract][Full Text] [Related]
16. Acute generalised exanthematous pustulosis and toxic epidermal necrolysis induced by carbamazepine.
Goh TK; Pang SM; Thirumoorthy T; Goh SG
Singapore Med J; 2008 Jun; 49(6):507-10. PubMed ID: 18581028
[TBL] [Abstract][Full Text] [Related]
17. Toxic epidermal necrolysis/Stevens-Johnson syndrome: current trends in management.
Dalli RL; Kumar R; Kennedy P; Maitz P; Lee S; Johnson R
ANZ J Surg; 2007 Aug; 77(8):671-6. PubMed ID: 17635282
[TBL] [Abstract][Full Text] [Related]
18. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective.
Mockenhaupt M; Kelly JP; Kaufman D; Stern RS;
J Rheumatol; 2003 Oct; 30(10):2234-40. PubMed ID: 14528522
[TBL] [Abstract][Full Text] [Related]
19. [Toxic epidermal necrolysis (Lyell's syndrome) caused by piroxicam, with fatal outcome from disseminated aspergillosis].
Coscojuela C; Charro L; Guallar A; Ferrer-Dufoll MA; Carapeto FJ
Med Cutan Ibero Lat Am; 1985; 13(4):291-300. PubMed ID: 3912630
[TBL] [Abstract][Full Text] [Related]
20. [Erythema multiforme vs. Stevens-Johnson syndrome and toxic epidermal necrolysis: an important diagnostic distinction].
Rabelink NM; Brakman M; Maartense E; Bril H; Bakker-Wensveen CA; Bavinck JN
Ned Tijdschr Geneeskd; 2003 Oct; 147(43):2089-94. PubMed ID: 14619195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
